title: Effect of silibinin and vitamin E on the ASK1-p38 MAPK pathway in D-galactosamine/lipopolysaccharide induced hepatotoxicity.
abstract: Apoptosis signal-regulating kinase 1 (ASK1), a redox-sensor mitogen-activated protein kinase kinase kinase (MAPKKK) that activates p38 MAPK pathways in oxidative stress-induced hepatotoxicity in D-galactosamine/lipopolysaccharide (D-GalN/LPS) model, is a key central pathway in which specific targeting of ASK1 deactivation is of a great therapeutic potential. We tested the effect of silibinin and vitamin E in curative and prophylactic manner of treatment on the negative modulators of ASK1, thioredoxin1 (Trx1), thioredoxin reductase1 (TrxR1), and the protein phosphatase (PP5), whereas they have previously proven to have hepatoprotective effect. Either curative or prophylactic silibinin and vitamin E groups significantly decreased ASK1 and p38 MAPK levels through increasing the gene expression of Trx1, TrxR1, and PP5 to reduce the oxidative stress as demonstrated by decreasing the levels of NADPH oxidase 4 (NOX4), TBARS and conjugated diene with a concomitant increase in the levels of GSH, CAT, and SOD. These results were confirmed by histopathology examination which illustrated progressive degenerative changes of hepatocytes such as hydropic degeneration, vacuolation, pyknosis, karyolysis, and loss of architecture of some cells in D-GalN/LPS treatment, and these features were alleviated with silibinin and vitamin E administration. In conclusion, silibinin and vitamin E decreased ASK1-p38 MAPK pathway through deactivating the upstream signalling ASK1 molecule via increasing the levels of Trx1 and TrxR1 as well as the PP5 to alleviate in D-GalN/LPS induced hepatotoxicity.
authors.affiliation: Department of Biochemistry, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt.
authors.forename: Reem M
authors.initials: RM
authors.lastname: Hashem
authors.affiliation: Department of Biochemistry, Faculty of Veterinary Medicine, Minia University, El Minia, Egypt.
authors.forename: Kamel Ma
authors.initials: KM
authors.lastname: Hassanin
authors.affiliation: Department of Biochemistry and Molecular Biology, Faculty of Medicine, Cairo University, Cairo, Egypt.
authors.forename: Laila A
authors.initials: LA
authors.lastname: Rashed
authors.affiliation: Department of Biochemistry, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt.
authors.forename: Mohamed O
authors.initials: MO
authors.lastname: Mahmoud
authors.affiliation: Department of Biochemistry, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt mohamed011159@pharm.bsu.edu.eg.
authors.forename: Mohamed G
authors.initials: MG
authors.lastname: Hassan
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000008:administration & dosage*; D056486:Chemical and Drug Induced Liver Injury / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology / Q000517:prevention & control; D005688:Galactosamine / Q000633:toxicity; D006651:Histocytochemistry; D008070:Lipopolysaccharides / Q000633:toxicity; D008099:Liver / Q000187:drug effects / Q000473:pathology*; D008111:Liver Function Tests; D048848:MAP Kinase Kinase Kinase 5 / Q000378:metabolism*; D018384:Oxidative Stress; D051381:Rats; D015398:Signal Transduction; D000077385:Silybin; D012838:Silymarin / Q000008:administration & dosage*; D016896:Treatment Outcome; D014810:Vitamin E / Q000008:administration & dosage*; D048051:p38 Mitogen-Activated Protein Kinases / Q000378:metabolism*
chemical_list: D000975:Antioxidants; D008070:Lipopolysaccharides; D012838:Silymarin; D014810:Vitamin E; D000077385:Silybin; D005688:Galactosamine; D048051:p38 Mitogen-Activated Protein Kinases; D048848:MAP Kinase Kinase Kinase 5
keywords: ASK1; PP5; Trx1; TrxR1; hepatotoxicity; p38 MAPK